Allosteric modulators of human A2B adenosine receptor

Area of Science:

• Pharmacology
• Medicinal Chemistry

Background:

• The A2B adenosine receptor (AR) is activated by high adenosine concentrations during tissue damage like ischemia and inflammation.
• Its low affinity for endogenous agonists makes A2B AR a significant pharmacological target.

Purpose of the Study:

• To evaluate 1-benzyl-3-ketoindole derivatives as potential positive or negative allosteric modulators of the human A2B AR.
• To characterize their modulatory effects on A2B AR activity.

Main Methods:

• Utilized binding and functional assays in CHO cells expressing human adenosine receptors (A1, A2A, A2B, A3).
• Investigated seven 1-benzyl-3-ketoindole derivatives (compounds 7-9).

Main Results:

• Compounds exhibited selective positive or negative allosteric modulation of A2B AR based on structural variations.
• Positive allosteric modulators (7a,b, 8a) enhanced agonist efficacy without altering potency.
• Negative allosteric modulators (8b,c, 9a,b) reduced both agonist potency and efficacy.

Conclusions:

• Several 1-benzyl-3-ketoindole derivatives were identified as selective positive (7a,b) or negative (8c, 9a,b) allosteric modulators of the human A2B AR.
• These compounds represent valuable pharmacological tools for developing therapeutics targeting A2B AR-related pathological conditions.